Travel Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer Last updated: September 13, 2026 4:08 am By oguntola aduragbemi Share 0 Min Read SHARE 🛡️ Just a quick check We’re checking your connection to prevent automated abuse Share This Article Email Copy Link Print Previous Article Trial supports MRI surveillance over preventive brain radiation in small-cell lung cancer Next Article Ivonescimab significantly improves overall survival versus pembrolizumab in advanced lung cancer Leave a Comment Leave a ReplyCancel reply FacebookLikeXFollowInstagramFollowLinkedInFollowMediumFollowRSS FeedFollow Most Read McDonald’s just introduced the US to its most popular international menu items. Here are the ones you should order and avoid. Cardano (ADA) Price Flashes 3 Warning Signals—Is a Pullback Coming? Uber shares slip after the company’s operating and marketing chiefs reportedly step down Gen Z traders lean into ETFs as risk appetite cools amid market slowdown, Binance Research finds IEOs Raise Half a Billion, Keep Fundraising Alive for Blockchain Startups Liverpool Football Club retains Alexis Mac Allister, confirms father One of Lyft’s early investors explains why he opted for the smaller company over Uber, and which growth metrics he’ll be watching in the coming quarters Independence Day 2026 | PM Modi announces AI skilling for one crore youth within a year 10 things you need to know before the opening bell Central bank market backstops risk fuelling leverage and future crises